米国のバイオディフェンス（生物防御）関連の迅速病原体同定および治療市場は、2021年の3億6,630万ドルから2026年までに5億1,830万ドルに達し、2021年から2026年までのCAGRは7.2％と予想されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update
Information Sources
Methodology
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Detection
Handheld Devices
Factors Contributing to the Market for Biodefense-Related Pathogen Identification
Highlights of the U.S. Market for Biodefense-Related Rapid Pathogen Identification
Treatment
Chapter- 3: Industry Overview
Introduction
Delivery and Detection
Treatment
Chapter- 4: Overview of Infectious Agents
Introduction
Categories of Bacterial Agents
Chapter- 5: Biodefense-Related Pathogen Detection Devices
Pathogen ID Devices by Testing Method
Types of Devices
Diagnostic Tools
Table 42 : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment, by Type, Through 2026
Figure 1 : U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment
Chapter- 6: Patents and Market Dynamics
Introduction
Patents on Rapid Pathogen Identification: 2019-2021
Pharmaceutical Market Opportunities/Challenges
Vaccine Market Opportunities/Challenges
Device Market Opportunities/Challenges
Chapter- 7: Company Profiles
Diagnostic Products
Vaccines
Pharmaceuticals
National Laboratories
Chapter- 8: Appendix: List of Acronyms
Table 78 : Acronyms Used in the U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatment
